Osteopore Ltd. (AU:OSX) has released an update.
Osteopore Ltd has announced significant advancements in their A$18.7m project with NDCS and A*STAR, successfully developing a 3D-printed technology for dental implants that enhances bone regeneration. The technology combines biological additives with polymer compounds, showing promising non-cytotoxic responses and improved osteogenic differentiation. This breakthrough positions Osteopore in the lucrative global dental bone graft and membrane substitute market, with plans to move into in vivo studies.
For further insights into AU:OSX stock, check out TipRanks’ Stock Analysis page.
